当前位置:Public Access >页面
Chinese/English
Efficacy and safety of bilateral subthalamic nucleus deep brain stimulation for the treatment of primary mid-advanced stage idiopathic Parkinson’s disease: a prospective, multicenter, randomized, single-blind, controlled clinical trial

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR-INR-16008951

研究题目:

Efficacy and safety of bilateral subthalamic nucleus deep brain stimulation for the treatment of primary mid-advanced stage idiopathic Parkinson’s disease: a prospective, multicenter, randomized, single-blind, controlled clinical trial

Study title:

Efficacy and safety of bilateral subthalamic nucleus deep brain stimulation for the treatment of primary mid-advanced stage idiopathic Parkinson’s disease: a prospective, multicenter, randomized, single-blind, controlled clinical trial

 注册状况:

 Registration:

False

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

18217122884

电子邮件

Email

i@cczhang.org

通讯地址:

上海市黄浦区瑞金二路197号瑞金医院32号楼1楼功能神经外科

Address:

Department of Function Neurosurgery , Building 32, Ruijin Hospital, No.197, Ruijin Second Road, Huangpu District, Shanghai

邮政编码

Postcode

200025

项目负责人所有单位:

上海交通大学医学院附属瑞金医院

Institution:

Ruijin Hospital, Shanghai JiaoTong University Scho

批准本研究的伦理委员会名称:

上海交通大学医学院瑞金医院伦理委员会

Name of the ethic committee:

Ruijin Hospital Ethics Committee Shanghai JiaoTong

研究疾病:

Study Ailment:

Parkinson's Disease

研究所处阶段:

Study phase:

Premarket

研究类型:

Type of Study:

Therapy Study

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

省(直辖市):

市(区县):

Country/Area:

China

Province:

Shanghai

City:

Shanghai
单位
Institution Ruijin Hospital, Shanghai JiaoTong University School of Medicine

预计起止时间:

Planned Duration:

2012/8/14 0:00:00-2014/9/30 0:00:00